Chunlong Zhao

Design, Synthesis and Biological Evaluation of Novel Osimertinib-Based HDAC and EGFR Dual Inhibitors

Hang Dong, Hao Yin, Chunlong Zhao et al. · Molecules · 2019 · 39 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Discovery of meta-sulfamoyl N-hydroxybenzamides as HDAC8 selective inhibitors

Chunlong Zhao, Jie Zang, Qin'ge Ding et al. · European Journal of Medicinal Chemistry · 2018 · 36 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Discovery of highly potent HDAC8 PROTACs with anti-tumor activity

Chunlong Zhao, Deng Chen, Feng‐Zhi Suo et al. · Bioorganic Chemistry · 2023 · 31 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

HDAC/MIF dual inhibitor inhibits NSCLC cell survival and proliferation by blocking the AKT pathway

Fangyuan Cao, Zhangping Xiao, Siwei Chen et al. · Bioorganic Chemistry · 2021 · 25 citations · Full text

Medicine, Oncology, Pharmacology +17

Development of selective HDAC6 inhibitors with in vitro and in vivo anti-multiple myeloma activity

Shunda Li, Chunlong Zhao, Guozhen Zhang et al. · Bioorganic Chemistry · 2021 · 24 citations

Medicine, Medicinal Chemistry, Pharmacology +9